Objective To study the relationship between the degree of fever within 48 hours of admission and the prognosis in children with bacterial bloodstream infection. Methods This study retrospectively analyzed the clinical data of all patients diagnosed with sepsis who were admitted to the pediatric intensive care unit (PICU) of Shengjing Hospital Affiliated to China Medical University between September 2008 and September 2016. The children with bacterial bloodstream infection were classified into 5 groups according to the maximum temperature within 48 hours of admission: < 36.5℃ group, ≥36.5℃ group (normal control), ≥37.5℃ group, ≥38.5℃ group, and ≥39.5℃ group. The mortality was compared between the five groups. Results A total of 213 children with bacterial bloodstream infection were enrolled, consisting of 5 cases in the < 36.5℃ group, 44 cases in the ≥36.5℃ group, 73 cases in the ≥37.5℃ group, 69 cases in the ≥38.5℃ group, and 22 cases in the ≥39.5℃ group. A total of 48 cases died among the 213 patients. A significant difference was observed in the mortality between the five groups (P < 0.01). The < 36.5℃ group and ≥39.5℃ group had significantly higher mortality than the normal control group. However, there were no significant differences in the mortality between the ≥37.5℃ and ≥38.5℃ groups and the normal control group. Conclusions In children with bacterial bloodstream infection, those with a maximum temperature below 36.5℃ or above 39.5℃ within 48 hours of admission have a significantly increased mortality.
Key words
Fever /
Bloodstream infection /
Mortality /
Child
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 张伟华. 发热[M]//金惠铭, 王建枝, 殷莲华, 等. 病理生理学. 北京:人民卫生出版社, 2013:103-113.
[2] Young P, Saxena M, Eastwood GM, et al. Fever and fever management among intensive care patients with known or suspected infection:a multicentre prospective cohort study[J]. Crit Care Resusc, 2011, 13(2):97-102.
[3] Eyers S, Weatherall M, Shirtcliffe P, et al. The effect on mortality of antipyretics in the treatment of influenza infection:systematic review and meta-analysis[J]. J R Soc Med, 2010, 103(10):403-411.
[4] Lee BH, Inui D, Suh GY, et al. Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis:multi-centered prospective observational study[J]. Crit Care, 2012, 16(1):450.
[5] Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock:2012[J]. Crit Care Med, 2013, 41(2):580-637.
[6] Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference:definitions for sepsis and organ dysfunction in pediatrics[J]. Pediatr Crit Care Med, 2005, 6(1):2-8.
[7] Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Third Informational Supplement[M]. Washington, DC:Clinical & Laboratory Standards Institute, 2013:M02-A10.
[8] American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia[J]. Am J Respir Crit Care, 2005, 171(4):388-416.
[9] 中华医学会儿科学分会呼吸学组, 《中华儿科杂志》编辑委员会. 儿童社区获得性肺炎管理指南(2013修订)[J]. 中华儿科杂志, 2013, 51(10):745-747.
[10] Yang MA, Lee J, Choi EH, et al. Pseudomonas aeruginosa bacteremia in children over ten consecutive years:analysis of clinical characteristics, risk factors of multi-drug resistance and clinical outcomes[J]. J Korean Med Sci, 2011, 26(5):612-618.
[11] Huang YC, Lin TY, Wang CH. Community-acquired Pseudomonas aeruginosa sepsis in previously healthy infants and children:analysis of forty-three episodes[J]. Pediatr Infect Dis J, 2002, 21(11):1049-1052.
[12] Laupland KB, Zahar JR, Adrie C, et al. Determinants of temperature abnormalities and influence on outcome of critical illness[J]. Crit Care Med, 2012, 40(1):145-151.
[13] Laupland KB, Shahpori R, Kirkpatrick AW, et al. Occurrence and outcome of fever in critically ill adults[J]. Crit Care Med, 2008, 36(5):1531-1535.
[14] Young PJ, Saxena M, Beasley R, et al. Early peak temperature and mortality in critically ill patients with or without infection[J]. Intensive Care Med, 2012, 38(3):437-444.
[15] Morris PE, Promes JT, Guntupalli KK, et al. A multi-center, randomized, double-blind, parallel, placebo-controlled trial to evaluate the efficacy, safety, and pharmacokinetics of intravenous ibuprofen for the treatment of fever in critically ill and non-critically ill adults[J]. Crit Care, 2010,14(3):R125.
[16] Niven DJ, Stelfox HT, Leger C, et al. Assessment of the safety and feasibility of administering antipyretic therapy in critically ill adults:a pilot randomized clinical trial[J]. J Crit Care, 2013, 28(3):296-302.
PDF(1297 KB)
